DPW
REGN icon

DiNuzzo Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

DiNuzzo Private Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74K Hold
6
– – ﹤0.01% 484
2026
Q1 		$4.64K Hold
6
– – ﹤0.01% 404
2025
Q4 		$4.63K Buy
6
+2
+50% +$1.36K ﹤0.01% 396
2025
Q3 		$2.32K Hold
4
– – ﹤0.01% 587
2025
Q2 		$2.1K Sell
4
-3
-43% -$1.67K ﹤0.01% 600
2025
Q1 		$4.44K Sell
7
-1
-13% -$688 ﹤0.01% 380
2024
Q4 		$5.7K Sell
8
-2
-20% -$1.68K ﹤0.01% 325
2024
Q3 		$10.5K Hold
10
– – ﹤0.01% 246
2024
Q2 		$10.5K Buy
10
+1
+11% +$969 ﹤0.01% 194
2024
Q1 		$8.66K Sell
9
-1
-10% -$951 ﹤0.01% 190
2023
Q4 		$8.78K Buy
+10
New +$8.23K ﹤0.01% 184

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

DiNuzzo Private Wealth's REGN Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 6 shares worth $3.74K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

DiNuzzo Private Wealth first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.5K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • DiNuzzo Private Wealth held 6 shares of Regeneron Pharmaceuticals worth $3.74K as of Q2 2026.
  • DiNuzzo Private Wealth left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #484 holding.
  • DiNuzzo Private Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • DiNuzzo Private Wealth's Regeneron Pharmaceuticals position peaked at $10.5K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.